Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.

Ly6C(low) monocytes differentiate into dendritic cells and cross-tolerize T cells through PDL-1.
复制标题

DOI:
10.4049/jimmunol.0803172
复制
发表时间:
2009-03-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Elkon KB
Elkon KB
中科院分区:
其他
文献类型:
--
作者:
Peng Y;Latchman Y;Elkon KB

文献摘要

参考文献

被引文献

相似文献

单核细胞来源的树突状细胞是抗感染免疫反应的积极参与者,但它们在稳态条件下是否在维持自身耐受方面发挥作用尚不清楚。在这里,我们研究了单核细胞的分化,它们摄取凋亡细胞的能力,以及它们在体内的潜在功能。我们观察到,Ly6C(Gr-1)低成熟单核细胞上调其在脾中的MHC II水平,表达高水平的PDL-1(程序性死亡配体1),并且在体内摄取凋亡细胞方面比Ly6Chigh未成熟单核细胞更有效。分选的循环Ly6Clow单核细胞能够交叉呈现细胞凋亡相关的OVA和可溶性OVA蛋白。含有凋亡细胞的单核细胞可进一步分化为CD11c+CD8MHC II+脾树突状细胞,维持α−-1的高表达。由于含有凋亡细胞相关OVA的野生型而非PDL-1缺陷的外周血单核细胞抑制了对OVA免疫的反应,因此单核细胞介导的T细胞耐受需要PDL-1的表达。这些观察表明,Ly6Clow成熟单核细胞可以通过依赖PDL-1的机制促进对凋亡细胞中自身抗原的耐受。
Monocyte-derived dendritic cells are active participants during the immune response against infection, but whether they play a role in maintaining self-tolerance under steady-state conditions is not known. Here we investigated the differentiation of monocytes, their ability to ingest apoptotic cells, and their potential functionality in vivo. We observed that Ly6C (Gr-1)low mature monocytes up-regulate their MHC II level in the spleen, express high levels of PDL-1 (programmed death ligand 1), and are more efficient than Ly6Chigh immature monocytes in the ingestion of apoptotic cells in vivo. Sorted circulating Ly6Clow monocytes were able to cross-present both apoptotic cell-associated OVA and soluble OVA protein. Monocytes containing apoptotic cells can further differentiate into CD11c+CD8α− MHC II+ splenic dendritic cells that maintained high expression of PDL-1. Since wild-type but not PDL-1-deficient peripheral blood monocytes containing apoptotic cell-associated OVA suppressed the response to OVA immunization, PDL-1 expression was required for monocyte-mediated T cell tolerance. These observations demonstrate that Ly6Clow mature monocytes can promote tolerance to self Ag contained in apoptotic cells through a PDL-1-dependent mechanism.
DOI: 10.1084/jem.194.6.769
发表时间: 2001-09-17
期刊: The Journal of experimental medicine
影响因子: --
作者:
Hawiger D;Inaba K;Dorsett Y;Guo M;Mahnke K;Rivera M;Ravetch JV;Steinman RM;Nussenzweig MC
通讯作者: Nussenzweig MC
DOI: 10.1172/jci1112
发表时间: 1998-02-15
影响因子: 15.9
作者:
Fadok, VA;Bratton, DL;Henson, PM
通讯作者: Henson, PM
DOI: 10.1182/blood.v92.11.4230.423k22_4230_4237
发表时间: 1998-12-01
期刊: BLOOD
影响因子: 20.3
作者:
McCloskey, TW;Bakshi, S;Pahwa, S
通讯作者: Pahwa, S
DOI: 10.1016/j.it.2004.09.013
发表时间: 2004-12-01
影响因子: 16.8
作者:
Carbone, FR;Belz, GT;Heath, WR
通讯作者: Heath, WR
DOI: 10.1126/science.1117729
发表时间: 2006-01-06
期刊: SCIENCE
影响因子: 56.9
作者:
Fogg, DK;Sibon, C;Geissmann, F
通讯作者: Geissmann, F